1290
UROLOGIE3418043010756103166209268327348392
PRO754804301074592154
PRAXI930804301074591147200220
/11968043010732
Urol.1273804301075682129149165
praxi.1457804301075077119158178193
2024;25(4):180-1841670804301074487128169183227271293335356370408447491521560599645
/23608043010731
www.urologiepropraxi.cz47028043010765133201214261288335354403453471515565592639689716757797816832872911
1841288026012657111170
PŘEHLEDOVÉ341207012660124182256312369444520587645
ČLÁNKY1008207012660115187259327395
Nové34136501063980117149
směry50636501063084116152188
v710365010636
léčbě7623650106296196132164
nádorů94236501063979118159195236
varlat119436501063673108139181209
3.3406380853651
Gurney4106390834482103142177208
JK,637639083256075
Florio731639083324785107122160
AA,911639083418498
Znaor10286390833876108146168
A,12156390834155
et12906390833456
al.1365639083324760
International1445639083145274108129168200222237275313346361
Trends1825639083335084122161188
in3407390831553
the408739083226095
Incidence519739083145284100138173211244277
of8127390833756
Testicular884739083336390113129161198214246267
Cancer:11677390834072110143176197211
Lessons1394739083316592119157195222
from1631739083194178136
3517837390833467
Years1866739083356698119146
and3408390833270109
414648390833465
Countries.5448390834077115153175196212246273287
Eur846839083336990
Urol.9528390834464102118130
2019;76(5):615-623.10988390833468100130143176208227260278290326356386408445479514526
4.3409380853652
Nicol412939083456092130146
D,5789390834657
Berney655939083367193132167199
DM,87493908346101115
Boormans10099390833674113135194227265291
JL,1321939083245770
et14129390833457
al.1489939083324861
EAU15709390833376119
Guidelines1709939083448398137172188203241276303
on34010390833776
Testicular4321039083336390113129161198214246267
Cancer,71610390833972110143176197207
presented9401039083386094121156194216249289
at124510390833254
the13151039083226095
EAU142610390833376118
Annual156110390834179117154187202
Congress17791039083407711615517621034011390832653
Paris4081139083356788104130
2024.55311390833468101133146
5.34012380853650
Huang41012390834482114152191
J,62112390832436
Chan67612390834078110148
SC,8441239083327386
Tin9491239083335088
MS,105612390835588100
et117612390833456
al.12511239083324861
Worldwide133112390835794115131170221237276311
Distribution,16611239083466187110132147186225247263301339352
Risk3401339083365278108
Factors,4691339083336395120157179207220
and71013390833271110
Temporal84113390833364123162202224257273
Trends11351339083335085123163189
of134513390833858
Testicular14231339083336492115131163201217250271
Cancer171513390834074112145179201
Incidence1936133908315543401439083324787123162195230
and59114390833372112
Mortality:72414390835595117142176192208231265280
A1025143908342
Global108814390834461100141175190
Analysis.130014390834181114130162190206233247
Eur15681439083337193
Urol168214390834466104121
Oncol.182414390834888121158175188
2022;5(5):566-576.34015390833468101136148183201235253265300334370393427461493506
6.34016380853550
Oosterhuis40316390834684110132165186223260275300
JW,7151639083248190
Looijenga81716390833167105120134168205243275
LHJ.11041639083317599111
Testicular12271639083326288110125156193208239259
germ-cell14991639083377192149170203236251266
tumours177716390832158114152189209236
in34017390831553
a408173908331
broader4541739083396198131170205226
perspective.6951739083397495123162197230254269302336348
Nat10581739083457799
Rev117217390833570103
Cancer.129017390833972110142176197208
2005;5(3):210-222.151317390833468104138149184202235252264300331362386417452487499
7.34018380853645
ÚZIS.4001839083448196128141
Cancer55618390834073111143177198
incidence770183908314528499138173211243277
2019–2021106218390833469100131168200234267298
in137518390831553
the14431839083226095
Czech155318390834071105138176
Republic.174418390833570109148187203218250263
8.34019380853652
Patel4061939083356789122138
HD,55819390834490101
Gupta67319390834482121143176
M,86319390835467
Cheaib94419390834078113145160199
JG,11571939083246982
et125319390833457
al.13231939083324861
Testis-sparing13981939083326390113128154175202241274295311349388
surgery18001939083266384122157178212
and34020390833270109
scrotal4622039083265880117139172187
violation6622039083324785101134155171209247
for9222039083195678
testicular10132039083225582105121153190206238259
masses128520390835890116143178205
suspicious15032039083266390129144176191229267294
for18102039083185677
malignancy:1900203908358903402139083153069107139178210243257
A618213908341
systematic6792139083265986109143201234256271303
review10032139083205587103138189
and121221390833270110
meta-analysis.134221390835893115148171203241274289321348363389403
Urol176521390834465103119
Oncol.190421390834786340223908331688497
2020;38(5):344-353.45222390833469101136148183218237270289301336371408431464497530542
9.34023380853650
Skoogh41123390833364102141182220
J,65223390832537
Steineck7102339083335589105143179213243
G,97423390834559
Cavallin-Ståhl105423390834074106139155171186225248280301335374390
E,146523390833346
et153223390833557
al.16102339083334962
Feelings169323390833367104120135174213240
of195423390833858
loss3402439083155380106
and46424390833270109
uneasiness59024390833876111142169184222257284310
or91824390833759
shame9942439083266496154189
after12012439083325176109131
removal134924390832155113151183216232
of159824390833757
a1672243908332
testicle17222439083225582105121153168203
by194224390833970
orchidectomy:3402539083375990128143182217249273310369399413
a772253908331
population-based82225390833977117155171203225240278316339379412438473513
long-term13532539083155392131153176209231289
follow-up1661253908318567287125176198237276
of195625390833756
testicular3402639083225582105121153190206238259
cancer61426390833264103135168190
survivors.8192639083266384119135167205227254267
Int11022639083155374
J1191263908325
Androl.123126390834179118139176192205
2011;34(2):183-192.145226390833468100127136171206225259277289319350384406437467500512
10.3402738085366983
Gilligan436273908343587388103141173210
T,65827390833341
Lin7122739083314683
DW,808273908344101111
Aggarwal93127390834178117149169222254269
R,121327390833548
et127427390833455
al.13422739083314659
Testicular14132739083336389112127158196210242263
Cancer,168827390834072110141174195205
Version190527390833668893402839083264179117
1.2024,4752839083344380114146178190
NCCN68328390834586124169
Clinical8692839083405570108123155188203
Practice10902839083355689121145160192226
Guidelines13332839083448297136171187202240275301
in165228390831553
Oncology.172228390834786118155171209248280291
J340293908324
Natl3792939083457899115
Compr50929390834077135174196
Cancer72029390834073111143177198
Netw.93429390834479102155165
2024;17(12):1529-1554.111529390833468101133145175204220252282300312342372405439463493523556591604
11.3403038085366678
Dieckmann4313039083456195128157216248286324
K-P,768303908335549195
Kulejewski8763039083357287122137171222249279295
M,118430390835467
Pichlmeier12643039083355081119134192227242276297
U,157430390834455
et164130390833456
al.17103039083324760
Diagnosis178330390834560921311692073403139083264167
of42031390833756
contralateral48931390833168106127149182197229251284305338353
testicular8553139083225582105120152190205237258
intraepithelial1126313908315527495128163202217240278313328343375390
neoplasia152931390833772111150166198224239271
(TIN)18133139083185470115134
in196031390831552
patients3403239083387192107142179201228
with5813239083506587125
testicular7193239083215481104119150188203234255
germ9873239083387293151
cell1151323908331647994
cancer:125832390833163101133166187200
systematic14713239083265885107141198230252267298
two-site178232390832174111134161175197231
biopsies3403339083385492131158172207233
are5863339083325387
more68633390835795116150
sensitive8493339083266199125139162177209243
than11053339083226092129
a1247333908332
single12923339083264178117132167
random14723339083205391130168225
biopsy.17103339083395492131158190200
Eur19233339083326990
Urol.34034390834465102118131
2007;51(1):175-183;discussion48634390833468104137147182213228260274286316345378400431462496507546561587620657684710725763802
183-185.13033439083346599121152183217229
12.3403538085366884
Hoei-Hansen44135390834482118133155201233272298333371
CE,8293539083407386
Rajpert-De9323539083366884123158180204224271306
Meyts125635390835489121145173
E,144635390833346
Daugaard150935390834678115154187219240278
G,180435390834458
et187935390833456
al.19523539083324760
Carcinoma3403639083407293123138175213270302
in65536390831451
situ7193639083264062100
testis,8313639083225581104119145157
the10013639083215993
progenitor11073639083385996135169207221243280301
of142036390833756
testicular14893639083215481103118150187202234254
germ17563639083377293150
cell1919363908331647994
tumours:34037390832260117156194215242255
a610373908331
clinical656373908331476299114146179195
review.8653739083215587103138189200
Ann108037390834179117
Oncol121237390834785117154170
Off13973739083476887
J1499373908324
Eur15373739083337091
Soc164237390833371104
Med176137390835489129
Oncol.190537390834785340383908331688497
2005;16(6):863-868.45238390833469105139150180211230263281293328363397419455490526539
13.3403938085366883
Dieckmann4433939083456196128158217250288326
K-P,789393908335549196
Wilken9053939083577389119153191
S,111639390833245
Loy118139390833269100
V,130139390833645
et136639390833456
al.14423939083324760
Treatment15223939083335084116138196231269291
of183339390833756
testicular190939390832256823404039083223769107123155177
intraepithelial537403908315537597130165205220243281317333348380395
neoplasia95340390833873112152168200227242274
(intratubular1248403908319347294115149171209248287302335356
germ16254039083387395153
cell1799403908331658196
neoplasia1916403908338733404139083387894126153168201
unspecified)56241390833776102142178211226244261296336356
with9394139083516790128
local10884139083155487120136
radiotherapy12444139083215594110148170209244266299339371
or163541390833860
with17164139083516689128
platinum-based1865413908339558710912534042390833875133155195228255290330
chemotherapy:68342390833169104162200222260295316349388420433
a1129423908332
survey11744239083266385119154185
of137242390833757
the14424239083215994
German154942390834480101159192230
Testicular179242390833263901131281601983404339083154768
Cancer42143390834073111143177198
Study6334339083325391130162
Group.80843390834466103141180193
Ann101443390834179117
Oncol114443390834786118155171
Off13284339083476887
J1429433908324
Eur14664339083336990
Soc157043390833270103
Med168643390835590129
Oncol.182943390834785118154170183
2013;24(5):1332-1337.34044390833468100130141176208228261280292321351384417437468498531563569
14.3404538085366984
Mortensen44145390835493114139173211237272310
MS,76845390835588100
Gundgaard88545390834482120159198230263284322
MG,122445390835499112
Daugaard135345390834577115154186218240278
G.164845390834357
Treatment17224539083335084116137196231269290
options34046390833878100115154193219
for5804639083195778
carcinoma6794639083326586118133171210269302
in100146390831553
situ10754639083264264103
testis.11984639083225683107122149163
Int13814639083155476
J1477463908325
Androl.152246390834280120141179195208
2011;34(4175146390833469101129137173208228261
Pt34047390833559
2):e32-36.414473908334526498133165186218253266
15.3404838085366883
Warde44348390835789110148183
P,64648390833539
Specht70548390833372107140178199
L,92448390833245
Horwich98948390834483104158173205243
A,125248390834155
et132748390833456
al.14034839083324760
Prognostic14834839083355693133171209236259274306
Factors18094839083326294118155177204
for3404939083195779
Relapse4414939083357187120160188224
in68649390831553
Stage7614939083335488128163
I946493908315
Seminoma98249390833369128143182221281314
Managed131749390835589127161200236277
by161549390833971
Surveillance:170749390833371931291641791952112442833405039083316577
A433503908341
Pooled48950390833572111126161201
Analysis.70550390834179112127159186201227240
J961503908324
Clin10005039083405570108
Oncol.112350390834786118155171184
2002;20(22):4448-4452.132250390833468105138150185219239272307325337371408445481504541578610644656
16.3405138085366985
Mortensen44051390835493114139173211237272310
MS,76551390835588101
Lauritsen88151390833164102123139161189224262
J,115851390832436
Gundgaard120951390834482120159198231263284322
MG,154651390835599112
et167451390833356
al.17455139083324760
A1820513908341
Nationwide1876513908345779911434052390833774124139177211
Cohort56452390833975113150171195
Study7725239083325289128159
of94352390833756
Stage10115239083325385123157
I1180523908315
Seminoma120752390833267123138175213270302
Patients15215239083346687102136173194221
Followed1754523908332698499136186220259
on34053390833776
a431533908332
Surveillance4785339083337091126160175190206238276308342
Program.8355339083355693133154187245258
Eur11085339083336990
Urol.121453390834464102118130
2014;66(6):1172-1178.136053390833468100131143179214233266284296326354383418438469496526559573
17.3405438085366877
Chovanec43854390834078117149183221256290
M,74854390835569
Cheng83754390834179114153192
L.105054390833145
Advances111654390834180113146185217251278
in141554390831553
diagnosis14895439083385486125164202229245271
and178154390833270110
treatment1911543908322447834055390833254112147185206
of56255390833756
testicular6345539083215582105120152190205237259
cancer.90855390833164102134168189199
BMJ.112355390833590116128
2022;126755390833468101136148
e070499.143055390833470103136172205240251
18.3405638085366985
Coleman4405639083407793128186218256
JM,7115639083247992
Coleman8185639083407793128186218256
RE,10895639083356982
Turner11865639083326687125160182
AR,13825639083417791
et148856390833456
al.15595639083324760
The163456390833272107
management17555639083589012816019923434057390835893131153
and51457390833270109
clinical6445739083314762100115147181196
course86157390833168107128155191
of107257390833857
testicular11505739083225683106121154192207240261
seminoma:143257390832661119135173211270303315
15176857390833464
years’18535739083316598119146159
experience34058390833465105141162177212250282316
at67358390833253
a743583908332
single7925839083264078117133168
institution.9765839083155379102118140178201216254292305
Clin12985839083405570108
Oncol142358390834786118155170
(R161058390831955
Coll16815839083407793108
Radiol).180658390833568107122160176196207
1998;10(4):237-241.34059390833464100135147177208228261278290325360392411442474504513
19.2140638085366881
Santoni22386390833265102123159197211
R,24666390833549
Barbera2531639083366888127162183215
F,27636390833237
Bertoni2817639083357090114151188203
F,30366390833338
et30916390833455
al.3163639083324659
Stage3238639083335385124158
I341363908314
seminoma34446390832661118132169207264296
of37576390833756
the2140739083225993
testis:2251739083225581103118143155
a242473908332
bi-institutional247373908339547591128153176191212250271286323361393407
retrospective289873908321547696133159197232264287302334367
analysis32837390833269101116147173187212
of35137390833756
patients3587739083387192106140178199226
treated2140839083224276107128161200
with2357839083516587125
radiation2499839083215391106137158173210248
therapy2764839083225993114146185215
only.2996839083387590121130
BJU31448390833559102
Int.326483908314527385
2003;92(1):47-52;33668390833568103136147181214230261275286320351369403435447
discussion2140939083385378109147172198212249287
52.2441939083346779
20.21401038085367287
Jones224010390832462101136163
WG,2416103908357101115
Fossa25441039083327096123156
SD,27131039083337889
Mead281510390835490121160
GM,298910390834398112
et311410390833456
al.31841039083314760
Randomized325710390833568106145183242257286320359
Trial3630103908332506597113
of375610390833756
30214011390833469
Versus22271139083366990117154181
20242611390833468
Gy251311390834374
in260611390831452
the26771139083216095
Adjuvant27901139083417995132165198236257
Treatment30661139083325084115137195230268290
of337411390833857
Stage34501139083325386125160
I3628113908315
Testicular3662113908332639011312821401239083316984116137
Seminoma:229012390833267125140178216274306318
A2621123908341
Report267512390833570109148169194
on288212390833775
Medical297012390835489129144175208223
Research32061239083367097132164185216254
Council347212390834077115153185200215
Trial3700123908332506597112
TE18,214013390833369101133147
European23091339083337193131172209242281
Organisation261213390834870110143183198225260282298338377
for30111339083195880
the31131339083226197
Research323213390833672100136169191223263
and351613390833372112
Treatment36501339083335186119142214014390835792130152
of231114390833756
Cancer238614390834073111143176198
Trial2602143908333506698113
30942273414390833468103139172
(ISRCTN18525328).29241439083193466101142178224256287321354389422454488506517
J3460143908324
Clin35021439083405570108
Oncol.362914390834786118155171183
2005;23(6):1200-1208.214015390833468104138149184219237270288300330360394430454485515549584598
21.21401638085367082
Travis22391639083335083114130156
LB,24121639083326780
Ng250916390834584
AK,26101639083417691
Allan27181639083415671104142
JM,28771639083247992
et298616390833456
al.30591639083324760
Second313616390833368101137176215
Malignant336816390835487102117156194226264286
Neoplasms36711639083458011821401739083395587113171197
and235017390833270109
Cardiovascular24721739083407394132147185217250276308346361394415
Disease29001739083456087121153180215
Following31281739083326985100138189205243282
Radiotherapy.342317390833568107122160182220255276309348379389
JNCI214018390832470110125
J2281183908324
Natl23201839083457799114
Cancer245018390834073111143176198
Inst.26631839083155379102116
2012;104(5):357-370.279418390833468100130142172204240259293311323358391425443476508541553
22.21401938085367287
Hellesnes22421939083447893108142168205239266
R,252319390833548
Myklebust258719390835485115131165204241267289
TÅ,28921939083326982
Fosså29891939083336995121154
SD,31581939083327787
et326019390833456
al.33311939083324759
Testicular34051939083336389111126157194209240261
Cancer36811939083407210921402039083316485
in223620390831552
the23002039083215993
Cisplatin24052039083405480118133165186200237
Era:2654203908333538597
Causes276220390834072109135169195
of296920390833756
Death303620390834680112133170
and321820390833169107
Mortality333720390835492113137169183198219252
Rates36012039083356889122148
in376020390831552
a2140213908331
Population-Based218221390833570108144158189209223260297318353385410443481
Cohort.267421390833974111148168191203
J2888213908324
Clin29232139083395367103
Oncol.303721390834683114149163175
2021;39(32):3561-3573.32232139083336697127134168199217249280297308341373405434452482514546578590
23.21402238085367287
Oliver22402239083476377110144165
RTD,241722390833569116126
Mason255622390835486113151189
MD,2757223908355100111
Mead288122390835489120159
GM,305322390834398111
et317622390833456
al.32452239083324760
Radiotherapy331722390833568107122159181219253274307346377
versus3707223908331658621402339083266390
single-dose22482339083264179118133168191231270296331
carboplatin25972339083326586125164204220252274289327
in294223390831553
adjuvant30132339083327186123156189227249
treatment32802339083214377109131189224262283
of358223390833756
stage36562339083265082121156
I2140243908315
seminoma:217524390832661119134172210268301313
a2508243908332
randomised25602439083215492131169227242269304343
trial.2923243908322435991106119
Lancet306224390833265103135169191
(London,32742439083185087125165203241254
England).354824390833370109125157195234254265
366(9482):293-300.214025390833469104123156192228261279291326360393415447482518531
24.21402638085367186
Albers22412639083415695131152179
P,243526390833540
Siener24892639083334782120155176
R,268026390833549
Kliesch27442639083355166101128160198
S,295726390833245
et301626390833457
al.30872639083324760
Risk31622639083355177107
Factors32832639083336294118155177204
for35022639083185677
Relapse35942639083357086118157184219
in214027390831552
Clinical22042739083405569107121153185200
Stage24172739083325385124158
I2587273908315
Nonseminomatous261527390834482120146180237252289327385417438474512538
Testicular31652739083336389112127158196211242263
Germ34412739083437899156
Cell36102739083407388103
Tumors:372527390833366214028390835796117145157
Results23132839083357097134150172200
of252928390833756
the26012839083226095
German271228390834479100159191229
Testicular29572839083336390113129161198214246267
Cancer324028390834073111143177198
Study34542839083325491131162
Group363228390834466103141180
Trial.2140293908333506597113126
J2281293908324
Clin23202939083405671108
Oncol.244429390834785118154170183
2003;21(8):1505-1512.264329390833468104137149184215230264282294323353388422444475505536566578
25.21403038085367287
Sweeney224330390833282117152190225257
CJ,25163039083406678
Hermans261130390834479100158191229255
BP,28823039083357176
Heilman29743039083447994109167199237
DK,32273039083468196
et333930390833456
al.34113039083324860
Results34883039083357097134149172199
and370330390833270109
Outcome214031390834785108138175233268
of242131390833756
Retroperitoneal24903139083357092113150190225246262284321359394426441
Lymph294431390833160118157195
Node315231390834583122157
Dissection33223139083456086113148180204219257296
for36303139083195678
Clinical3721313908339546921403239083375182114129
Stage22813239083325385123157
I2450323908314
Embryonal247632390833289127148181217255286301
Carcinoma27893239083397192122137174211268299
–3100323908335
Predominant31473239083345488126163220235272303340361
Testis35203239083326288110125150
Cancer.3683323908339711082140333908331658696
J2252333908324
Clin22913339083405570108
Oncol.241533390834785117154170183
2000;18(2):358-358.261333390833569105141154184215234268286298333366400423455488522536
26.21403438085367187
Blok22403439083355189120
JM,23733439083247992
Pluim24783439083355088103161
I,265234390831427
Daugaard269234390834578115154186219240278
G,298334390834457
et305334390833456
al.31223439083324861
Lymphovascular319634390833159118157196234266299325358395411443464
invasion3673343908315538411721403539083264178116
and226935390833269108
presence23903539083385993120154192224257
of266035390833756
embryonal272835390833492131152186223261293308
carcinoma30493539083316384115130167205263295
as335735390833157
risk3427353908321366291
factors35313539083185183107144165192
for37363539083185576
occult214036390833770101139154176
metastatic233536390835893115148174198230252267299
disease26533639083395480115147173208
in288036390831553
clinical2952363908331466199114146179195
stage31663639083264982121156
I3341363908315
nonseminomatous33753639083377511414017523324828632438341521403739083225997123
germ22813739083387394153
cell2452373908331658196
tumour:256637390832260117156194215229
a2813373908332
systematic28633739083265986109143201233255270302
review31833739083215587103138189
and339037390833270109
meta-analysis.3517373908358931151481702022412732140383908315477488115128
BJU228338390833660105
Int.2403383908315537488
2020;125(3):355-368.250638390833468101135148178208243261294311323358391424446478513548562
27.21403938085367180
Tandstad22333939083336199138164187220259
T,250539390833241
Ståhl25593939083335487125140
O,271239390834758
Håkansson278339390834477107140178205231269308
U,310439390834455
et317239390833456
al.32413939083324760
One331439390834786120
course344839390833168106127154189
of365039390833757
adjuvant37203939083317021404039083155285118156178
BEP233540390833569104
in245740390831452
clinical2527403908331466199114146179194
stage27394039083264982121156
I2912403908315
nonseminoma294540390833776114140175233248286325383415
mature337840390835789111149170204
and360040390833270109
expanded372640390833466214041390833973112152188228
results23894139083215683122137160189
from25994139083184179139
the27594139083226197
SWENOTECA287741390833392127173222255290331374
group.32734139083386098137177190
Ann348441390834281120
Oncol.362541390834887120158174188
2014;25(11):2167-2172.214042390833468100131143178213230262290304316351383414447465496528557591604
28.21404338085367389
Albers22504339083415796132154181
P,245243390833540
Siener25134339083324782121156178
R,271143390833650
Krege27824339083355792132167
S,297043390833245
et303643390833457
al.31134339083324861
Randomized319543390833569107146185244259288323363
Phase357843390833674106133168
III37674339083153046
Trial21404439083335167100116
Comparing227744390834179138178212234250289329
Retroperitoneal26274439083367295117155196232254270294331371407439455
Lymph310444390833161121161200
Node332544390834685126162
Dissection35084439083466289116152186210226265305
With21404539083577496134
One228845390834786121
Course242345390834077115137164199
of263645390833757
Bleomycin27074539083355186125183214245260298
and301945390833270109
Etoposide31434539083325390130169195210249284
Plus34414539083355088114
Cisplatin35694539083405581120136169190206243
Chemotherapy214046390834078113171209231269304325358397429
in258746390831553
the26584639083226095
Adjuvant27714639083418095132165198236258
Treatment30474639083335084116137196231269290
of335646390833756
Clinical34314639083395570108123155187203
Stage36524639083335487126160
I2140473908315
Nonseminomatous217147390834583122148183241256294332390423444481520546
Testicular27334739083336390113129161198214246267
Germ301747390834379100158
Cell31924739083407389104
Tumors:331247390833366124163184211224
AUO355247390834184131
Trial3700473908332506597113
AH214048390834186
01/94.22414839083346688122157170
J2426483908324
Clin24664839083405570108
Oncol.258948390834786118155171184
2008;26(18):2966-2972.278848390833468104140152187221240271302320332367401437473496527561594628641
29.21404938085367285
Beck224449390833571103133
SDW,239649390833277135144
Bey255949390833570102
AL,26794939083417386
Bihrle27844939083355088109125160
R,296249390833650
et303049390833456
al.31054939083324760
Ejaculatory31834939083334880112150165197219256278312
Status35134939083325486108146172
and370449390833270109
Fertility21405039083326687111126141156178211
Rates23645039083356889122149
After25265039083405984117138
Primary26775039083345570127159180214
Retroperitoneal29045039083356991113149189224245260282319357391423438
Lymph335550390833159117156194
Node356250390834482121156
Dissection.37305039083456121405139083265388120145160198236249
J2405513908324
Urol.244451390834465102118131
2010;184(5):2078-2080.259051390833469100132145175206242262295314325361395427461483514548584619632
30.21405238085367287
Classen22395239083405587113139174211
J,246352390832436
Schmidberger251252390833264102159174212251286307345380401
H,292552390834457
Meisner299452390835589104130168202223
C,323052390834052
et329552390833456
al.33635239083324760
Radiotherapy343652390833567106121158180218253274306345376
for21405339083185678
Stages22325339083325486125160187
IIA/B2433533908315307299136
Testicular25835339083336390113129161198214246267
Seminoma:286553390833267125140178216274307319
Final31985339083334886118133
Report334653390833570109148170194
of355553390833756
a3626533908331
Prospective36725339083355593119214054390833976110135151184220
Multicenter238154390835694110134150183217256279314336
Clinical27385439083415672111127160194210
Trial.29695439083335167100116130
J3120543908325
Clin31665439083415772111
Oncol.329954390834888121159175189
2003;21(6):350954390833570107142154190222238272291303
1101-1106.21405539083346293125144175202234269283
31.21405638085377183
Domont224556390834686146185224247
J,251356390832437
Massard257156390835689117144178200239
C,283156390834154
Patrikidou29075639083356891113129160177217256295
A,322356390834257
et330156390833558
al.33805639083324862
A3463563908342
risk-adapted352656390832137649511614918922226321405739083225595
strategy22545739083265071104126160199231
of250557390833756
radiotherapy25805739083215493108146168206241263296335366
or296557390833859
cisplatin-based30445739083314672111127159181196234256296329356391431
chemotherapy34945739083316910416220022226029521405839083215493124
in228358390831553
stage23545839083275082122156
II252958390831530
seminoma.257858390832661119134172211269301314
Urol291158390834465102118
Oncol304858390834786118155171
Semin323858390833267125140178
Orig34355839083476984123
Investig.35775839083155384118145168184223236
2013;31(5):697-705.214059390833468100130141176207222256274286322356388407438471505517
32.3940638085367085
Heinzelbecker4038639083447893131159193208247282314344377398
J,44496390832435
Schmidt44976390833264101159173212234
S,47436390833345
Lackner4801639083316495125164198219
J,50336390832435
et50816390833355
al.5149639083314659
Therapy52216390833271105126159197228
of54626390833655
clinical55306390833146603940739083385385117133
stage4086739083265082121156
IIA4256739083153071
and43407390833270109
IIB4463739083153066
seminoma:45427390832661119134172210269301313
a486973908332
systematic4914739083265986109143201233255270302
review.5229739083215587103138189200
World54427390835894116132171
J394083908324
Urol.39798390834465102118131
2022;40(12):2829-2841.41268390833468101135148183218238270300318329365398432466490520554591621630
33.3940938085367186
Giannatempo4040939083445991129167199221255313352391
P,44449390833640
Greco4498939083436599132169
T,46809390833342
Mariani47369390835486108123155193208
L,49589390833145
et50179390833456
al.5087939083314760
Radiotherapy51609390833668107123161182221256277310349380
or55549390833759
chemotherapy394010390833169104162200222261296317350389420
for43741039083195678
clinical4466103908331466199114146179195
stage46751039083264982121156
IIA48451039083143071
and493010390833270109
IIB50531039083153066
seminoma:513310390832661119134172210268301313
a5460103908332
systematic55061039083265885394011390832255113146167183215
review41681139083215587103138189
and437111390833270109
meta-analysis449411390835792114147169202240272287319346361387
of489511390833757
patient49651139083397294109144182203
outcomes.51821139083377698129166224259286300
Ann549511390834179117
Oncol394012390834786118155171
Off41261239083476887
J4228123908324
Eur42681239083326990
Soc437312390833371104
Med449212390835590129
Oncol.463612390834786118155171184
2015;26(4):657-668.483512390833469100130141176210229262279291326360394412449485520534
34.39401338085377591
Daneshmand405213390834679118154182221280313352392
S,446613390833346
Cary45331339083417597132
C,468613390834154
Masterson476113390835689117141175197225265304
T,508613390833443
et515013390833558
al.52291339083324862
Surgery53121339083337293133169190225
in555913390831554
Early39401439083336687103135
Metastatic409514390835590113145172195228250266298
Seminoma:441314390833368126141179218276309321
A4754143908341
Phase481614390833573105132167
II500414390831430
Trial5054143908333506698113
of518814390833757
Retroperitoneal52651439083367193115152192228249265287324394015390833873104120
Lymph407615390833260119158196
Node428915390834583123158
Dissection44631539083456187114149181205221259297
for47771539083185677
Testicular48711539083326390113129160198214246267
Seminoma515515390833267125140178216275307
With54781539083587496135
Limited394016390833248107123146180221
Retroperitoneal41821639083367295117155196233254271294332371407440456
Lymphadenopathy.465916390833261121161201234274310349388429463485524556566
J5246163908325
Clin52921639083415772111
Oncol.542416390834888121159175188
2023;41(16):3009-3018.394017390833468101136147182212227259290308320355390426461485517552584615628
35.39401838085367186
Hiester40441839083445994121144178199
A,426118390834155
Che433418390834078113
Y,446518390833544
Lusch45271839083316894127165
A,471018390834155
et478318390833456
al.48571839083324860
Phase493618390833572104131166
25120183908334
Single-arm51721839083334885124140175198230251310
Trial5500183908332506597113
of394019390833757
Primary40151939083355571129161182216
Retroperitoneal42491939083367193114152191227248264286323361396428444
Lymph471119390833160118157196
Node492519390834583123157
Dissection51001939083466187114149182206221259298
in541619390831452
Patients5486193908335678910439402039083347294121
with40792039083516689127
Seminomatous422420390833368125141178217275307329366404430
Testicular46722039083336491114129161199214246267
Germ495720390834480101159
Cell51342039083407490105
Tumors525720390833266123162183211
with54862039083506688126
Clinical39402139083405570108123155188203
Stage41592139083325386125160
IIA/B4334213908315307199136
(PRIMETEST).44852139083185489105160193228263296331353364
Eur48642139083336990
Urol.497021390834364101117130
2023;84(1):25-31.511621390833468101135147182218238270284296331366388420451461
36.39402238085367187
Loriot40392239083316889104142163
Y,421522390833543
Texier42702239083326394109143164
M,444622390835467
Culine45262239083397590105142177
S,471522390833245
et477222390833456
al.48402239083324760
The491222390833271105
GETUG503022390834376111155199
SEMITEP524222390833264118133167200235
Trial:5490223908332496495111122
De-escalating394023390834580102138165196229244275297312349387
Chemotherapy434023390833977111168206227265300320353391422
in477523390831451
Good-prognosis483923390834381120159180220241278317354392418433458
Seminoma531023390833266123138175213271303
Based39402439083356895130169
on412624390833876
Fluorodeoxyglucose42192439083324785123144182221256295325359397413450482519546581
Positron48172439083357298113136157194233
Emission506724390833290105131158173211249
Tomography/Computed533324390833367125163203224257394025390833977108131170207266305343366399439
Tomography.439425390833367125163203224257296335365375
Eur47852539083326990
Urol.489025390834465102118131
2022;82(2):172-179.503625390833569102136149184217235269287299328358392412443473506517
37.39402638085377383
Nicolai40452639083466296134151184201
N,426726390834660
Nazzani434926390834680111143178218234
S,460526390833347
Tesone46742639083336594133174210
A,490626390834257
et498526390833558
al.50652639083334963
Retroperitoneal51502639083367396119158199236258275299337377414447463
lymph-node394027390831547105144183205244283322357
dissection43112739083385379106141173198213251289
(RPLND)46142739083195591122167213231
as485927390833158
upfront49312739083377695118155193215
management516027390835789127160199234291327365386
in556027390831553
stage39402839083264982121156
II410928390831430
germ-cell41512839083397394153175209242258273
tumours:443728390832259117155193215242254
Evaluation47042839083336497113150182204219257295
of501228390833857
safety50822839083265978112134168
and526328390833270109
efficacy.5385283908333527087119152184218228
Tumori.394029390833366124162184199212
2023;109(4):379-386.416829390833468101136147177209244263296313325360392426449482516552565
38.39403038085367287
Bokemeyer404030390833573103136194228259292313
C,436630390834052
Kollmannsberger44323039083347187101158190227264290328363383421455475
C,492130390834052
Stenning49863039083335386123161175212251
S,525030390833244
et530830390833455
al.53763039083324759
Metastatic54483039083558911114339403139083264981102116148
seminoma410131390832661118132169207265296
treated44113139083224276107128161200
with46243139083516688125
either47633139083344870107142162
single49393139083264077116130164
agent511731390833270104142162
carboplatin52933139083316484123161200215247268282319
or394032390833758
cisplatin-based40093239083314570108123154175190226248287319344378417
combination443732390833167124162177214245266280317355
chemotherapy:480332390833168102159196217254288308340378409421
a5236323908331
pooled527832390833977114129163202
analysis5491323908332691003940333908315467286112
of406533390833856
two413533390832174111
randomised42593339083215390129166224238264298337
trials.4609333908322435889104129142
Br476433390833656
J4834333908324
Cancer.487133390834073110141174195204
2004;91(4):683-687.508933390833467103138150184216230262279290325360393414451485518523
39.39403438085367083
King40363439083355188126
J,417534390832436
Dropcho422334390834566103142174212249
S,448534390833244
Beeler454234390833570104120154175
S,472934390833245
et478634390833456
al.48543439083324760
A4926343908341
phase497934390833876108134169
II516034390831530
trial5202343908322435889104
evaluating53193439083346598113150182203218255294
the39403539083215993
efficacy4046353908333526987118151182215
of427435390833755
cabozantinib434235390833163102140168201238259274311326364
in471935390831452
the47833539083225994
treatment48893539083214276107129186220258279
of518035390833756
patients52493539083387092106141178199226
with54883539083506587125
refractory3940363908321557496129161185222244278
germ-cell42353639083387394153175209243258273
tumors452636390832159117156177204
(GCT).474836390831861102137159170
J4936363908324
Clin49773639083405570108
Oncol.510336390834685117154170183
2022;40(6_530336390833569102136149183219239272309
suppl):TPS428–TPS428.394037390832663102142158177189218255288324357390427457494527563596629643
40.39403838085367489
Necchi404738390834580112143181196
A,426138390834155
Anichini43343839083417994126164179217232
A,458438390834155
Raggi465738390833568107146161
D,483638390834556
et491038390833456
al.49843839083314760
Brentuximab50613839083365791129151189220236293326365
Vedotin54443839083356810814639403939083223775
in403239390831553
CD30-Expressing410239390834085118152176210243282304338365391406444483
Germ460239390834480101159
Cell47783939083407490105
Tumors490039390833366124162184211
After51283939083416085119140
Chemotherapy52853939083407811317120923126930439404039083215493124
Failure.4079403908333627793130151185197
Clin42924039083405570108
Genitourin441540390834479117132155192230251267304
Cancer.473540390834073111143176198208
2016;14(4):261-264.e4.495840390833569100132144174205224257275287322355386404435469505518553589602
41.39404138085366880
Albany40334139083415694127164195
C,424041390834053
Fazal43054139083326190123139
Z,445641390833850
Singh45194139083324784123160
R,469241390833548
et475341390833456
al.48214139083324760
A4893413908341
phase494641390833977109135169
15128413908334
study51744139083264987125157
of534341390833756
combined541241390833167125164179394042390833772111
guadecitabine406342390833875107145180212227249281320335372407
and448242390833269108
cisplatin46024239083314672110126157179194231
in484542390831552
platinum49104239083385485107122159196253
refractory5176423908320547294127158182219240273
germ54624239083387293150
cell3940433908331658196
cancer.405143390833164102134168189199
Cancer426643390834073111143176198
Med.447943390835489129142
2021;10(1):156-163.463643390833569102133141171203222254269280310340375398429460494506
42.39404438085367086
Tandstad40444439083336199138164187220259
T,432144390833341
Stahl43804439083335487125140
O,453844390834758
Dahl461544390834577115131
O,476444390834758
et484044390833456
al.49144439083324760
The499244390833372107
ABC-study:511744390834177118131158181219258290304
A5439443908341
randomized54984439083205391394045390833876135150179213252
phase420845390833977110136171
III43954539083153046
study44574539083264987126158
comparing463145390833168126165198219235273312
one495945390833776111
course508645390833168106127154189
of529145390833757
adjuvant53644539083317086123156189227248
bleomycin,39404639083395589128186217249264302314
etoposide,42684639083345693133172198213252287299
and458146390833169108
cisplatin47034639083314673111127160181197234
(BEP)49514639083195588123141
and510646390833169109
one522846390833776111
course535346390833168106127154189
of555646390833757
carboplatin39404739083316485125164203219251273288326
AUC7428547390834184124159
in446347390831553
clinical4535473908331466199114146179194
stage47484739083264982121156
I4923473908315
seminomatous495747390832661119134172210268301322359398424
testicular5400473908321558210512015219039404839083154767
cancer.402048390833164101133166187197
J4230483908324
Clin42674839083395469106
Oncol.438648390834685117153169181
2017;35(15_suppl):45804839083346899128138172205222253283319346383422461477496507
TPS4593–TPS4593.510048390833269101137169201234269299335368404436468500513
43.39404938085367287
Swiss40484939083338399125152
Group422149390834466104142182
for44234939083195779
Clinical45224939083415671110125157190206
Cancer474949390834073112144178200
Research.49694939083367199134166188219257271
Reduced526149390833571110148181215255
Intensity55374939083155339405039083225897125141165200
Radio-chemotherapy416350390833670111127167192227266303363403426466503525560601633
for48195039083195881
Stage49235039083345690131167
IIA/B51135039083163275104142
Seminoma.527850390833370130146186226286320334
NCT03937843.394051390834586121155188222254287320356389401
44.39405238085367489
Feliciani4043523908332668297129144175213228
G,428452390834457
Mellini435452390835590105120135173188
L,455552390833145
Carnevale46135239083407293132167199232247282
A,490852390834155
et497652390833456
al.50455239083324760
The511852390833271106
potential52375239083397899133171192208240255
role55055239083215874108
of394053390833757
MR401253390835490
based41185339083387198133172
radiomic43055339083215493108146205220252
biomarkers45725339083395492150183204234269290317
in490453390831553
the49725339083226095
characterization508253390833169102123156188212246267283312345367382420459
of555653390833757
focal39405439083185689122137
testicular40925439083225682106121153191206238259
lesions.4367543908315497691129167194207
Sci45905439083326480
Rep.468554390833570109122
2021;11(1):3456.482254390833469101133141171199214246260272307343375410423
45.39405538085367186
Lobo404055390833169108147
J,420155390832436
Zogchel425155390833875114146184219235
LMJ450055390833187113
van,462655390833265103116
Nuru475555390834583104142
MG,491155390835499112
et503755390833456
al.51075539083324760
Combining518155390834077135174190228243281320
Hypermethylated55155539083447639405639083397495154189211249280296328350384423
RASSF1A438256390833578112144176208245
Detection464656390834580103137169193209247285
Using49505639083436984122161
ddPCR512956390833877113154189
with53375639083506688127
miR-548256390835773108130
-371a-3p39405739083215386118147169202241
Testing:42015739083336491114129168207219
An444157390834179
Improved454157390831472112133171203237277
Panel483957390833567105140156
of501657390833756
Liquid50935739083314786124139178
Biopsy52915739083365189129156189
Biomarkers55005739083365189394058390835892114145180202230
for41925839083185780
Testicular42935839083336592116132165204220253275
Germ458958390834581103163
Cell47745839083407591107
Tumor490258390833468127167189
Patients.51125839083366992107143182205233247
Cancers538158390834074113146181203231
(Basel).39405939083195487114149165184195
2021;13(20):5228.415059390833468101133141171201219253287305317353386421454468
www.urologiepropraxi.cz5107380033720642063468183292310751141129414521516165618151906205822172309244425762641269828222947
Urologie51071110289160252387454589726792916
pro147171110289140233368
praxi188471110289141233356482549